Get started
Work

Is perfect the enemy of good? Weighing the evidence for biparametric MRI in prostate cancer

Year: 2021
Type: article
Abstract: The role of multiparametric MRI in diagnosis, staging and treatment planning for prostate cancer is well established. However, there remain several challenges to widespread adoption. One such challenge is the duration and cost of the examination. Abbreviated exams omitting contrast-enhanced sequences may help address this challenge. In this review, we will discuss the rationale for biparametric MRI for detection and characterization of clinically significant prostate cancer prior to biopsy and synthesize the published literature. We will weigh up the advantages and disadvantages to this approach and lay out a conceptual cost/benefit analysis regarding adoption of biparametric MRI.
DOI: 10.1259/bjr.20210840
Authors: Alexander P. Cole, Bjoern J. Langbein, Francesco Giganti, Fiona M. Fennessy, Clare M. Tempany, Mark Emberton
Institutions: Brigham and Women's Hospital, University College London Hospitals NHS Foundation Trust, Harvard University, University Hospital Magdeburg, Otto-von-Guericke-Universität Magdeburg, University College London, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W3217713401
FWCI: 0.283
Cites: 67
Cited by: 2
Related to: 10